Awareness and acceptability of HPV vaccination among parents of young girls in northern Morocco: a mixed-methods study Authors: Saloua Lemrabett, Fatima Zahrae Elhailouch, Adil Gourinda, Nadya Mezzoug, Adil Najdi Published: 2026 ABSTRACT BackgroundMorocco implemented a national HPV vaccination program in 2022 as part of its primary cervical cancer prevention strategy. The program faces several challenges, with very low vaccination coverage, likely due to parental hesitancy. This study aimed to assess the acceptability of HPV vaccination among parents of young girls.MethodsA mixed-methods study was conducted between 2024 and 2025 among parents of young girls in northern Morocco. We combined quantitative method with face-to-face questionnaire, analyzed using descriptive, univariate and multivariate statistics; and qualitative data from a focus group analyzed thematically.ResultsA total of 300 parents were recruited, with a mean age of 37.96 ± 8.0 years and a sex ratio F/M of 2.33. Only 10% of participants knew that cervical cancer is caused by persistent HPV infection. Awareness of the national HPV vaccination program was low (8.7%). Overall, 60% of parents reported good acceptability of HPV vaccination. Older age and formal education were independently associated with HPV vaccination hesitancy (OR = 1.046; 95% CI: (1.013–1.081; p < 0.006 and OR = 2.404; 95% CI: 1.334–4.331; p < 0.004). Qualitative findings indicated excellent acceptability of HPV vaccination, with lack of uptake primarily due to insufficient awareness of the disease, its vaccine, and the Moroccan HPV vaccination program.ConclusionOur study found no evidence of an association between the low HPV vaccination rate in Morocco and parental acceptability. Nevertheless, limited awareness of the national HPV vaccination program remains a major concern. Barriers to HPV vaccination should be further explored through implementation research.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12885-026-16111-1. Background Cervical cancer remains a major public health concern [1]. In 2022, it was the fourth most frequently diagnosed cancer among women worldwide with around 660 000 new cases, and 350 000 deaths, of which 94% occurred in low- and middle-income countries [1]. In 2020, about one in five children who lost their mothers to cancer were orphaned as a result of cervical cancer [2]. In Morocco, cervical cancer ranks as the third most frequent cancer among women and the sixth most common cancer overall in the country [3]. A national program for cervical cancer prevention was implemented in Morocco in 2010 [4]. It targets women aged 30 to 49 years through visual inspection with acetic acid [4]. Positive cases are referred to reproductive health referral centers, while negative cases are advised to undergo screening again every three years [4]. The target screening coverage is specified by the provincial or regional program coordinator [5]. Additionally, HPV vaccination became available in the private sector in Morocco in 2008 with the quadrivalent vaccine Gardasil® [6]. In 2020, the World Health Organization (WHO) adopted the Global Strategy to Eliminate Cervical Cancer [7]. This strategy aims to achieve the 90–70–90 targets by 2030: 90% HPV vaccination coverage among girls aged 15 years old, 70% screening coverage among women aged 35 and 45, and 90% of women diagnosed treated properly [7]. As part of this global effort, Morocco has aligned its national policies with the WHO strategy and introduced free HPV vaccination into its national immunization program in 2022 [8, 9]. The goal is to ensure that by 2030, at least 90% of 11-year-old girls nationwide receive the full two-dose series of the quadrivalent HPV vaccine (Gardasil®), administered six months apart [8]. While the secondary prevention program has been evaluated in 2017, no evaluation of HPV vaccination coverage has been conducted [3, 5]. Several studies have reported the persistently low HPV vaccination coverage in Morocco, emphasizing the multiple barriers to its implementation [10–12]. According to the WHO, in 2024, HPV vaccination coverage by age 15 approached 0% in the Eastern Mediterranean region, which includes Morocco [13]. The success of HPV vaccination programs largely depends on parental acceptability, as these programs primarily target young adolescents who rely on their parents authority for vaccination decisions [14]. Furthermore, no study has discussed its acceptability in Morocco after the implementation of this vaccination program in 2022. This mixed-methods study aims to assess the awareness and acceptability of the HPV vaccination program among parents of young girls, and to identify factors associated with vaccination hesitancy uptake. Methods Aim, design, and setting of the study This study aims to assess the awareness and acceptability of the HPV vaccination program among parents of young girls in northern Morocco. A mixed-methods approach was used combining a cross-sectional study conducted from December 2024 to February 2025, and a qualitative focus group session in December 2025. Study population and sampling Parents of young daughters were recruited from the outpatient consultation area of the diagnosis center and from the pediatric consultations at Mohammed VI University Hospital of Tangier. Inclusion criteria: Parents (mothers or fathers) of Moroccan nationality with at least one daughter under 15 years old who provided informed consent to participate. Exclusion criteria: Parents of non-Moroccan nationality or who refused to participate in the study. A homogeneous focus group was conducted with parents recruited from the outpatient consultation area, to provide a safe environment for discussion. The sample size was calculated using a single population proportion formula with a 95% confidence level, a precision of 5% and an assumed acceptability of HPV vaccination of 50% due to the lack of local estimates. The required sample size was 384 participants. However, 300 participants were included, which still allows estimation of the proportion with precision of approximately 5.54% at the 95% confidence level. Data collection Quantitative data were collected using a face-to-face questionnaire specifically developed for this study. Surveys were administered while parents were in the waiting area. Data were collected and managed using the REDcap platform hosted at Mohammed VI University Hospital of Tangier. REDCap (Research Electronic Data Capture) is a secure, web-based software platform designed to support data capture for research studies. The questionnaire underwent multiple rounds of piloting and revision to ensure clarity and relevance. The final version of the questionnaire addressed the following domains: Socio-demographic characteristics.Personal and family medical history.Knowledge regarding cervical cancer and HPV.Knowledge regarding the national HPV vaccination program in northern Morocco.Acceptability of HPV vaccination assessed using a binary (Yes/No) question. Socio-demographic characteristics. Socio-demographic characteristics. Personal and family medical history. Personal and family medical history. Knowledge regarding cervical cancer and HPV. Knowledge regarding cervical cancer and HPV. Knowledge regarding the national HPV vaccination program in northern Morocco. Knowledge regarding the national HPV vaccination program in northern Morocco. Acceptability of HPV vaccination assessed using a binary (Yes/No) question. Acceptability of HPV vaccination assessed using a binary (Yes/No) question. Qualitative data were collected among parents of girls aged under fifteen years to explore their attitudes toward HPV vaccination. The discussion was conducted in a private room, audio recorded in the Moroccan dialect, and further translated into English. The focus group guide was designed to create a comfortable environment for open discussion and included questions related to awareness and knowledge regarding cervical cancer and the national HPV vaccination program in northern Morocco as well as attitudes toward vaccination. Two trained members of the research team led the session, which continued until participants had no further comments. Alongside collecting participants’ perspectives, the researchers provided details about the HPV vaccination program and answered questions, enabling a two-way exchange. Finally, qualitative findings were triangulated with quantitative data to identify areas of convergence and divergence regarding factors influencing positive attitudes toward vaccination. Statistical analysis Quantitative data were analyzed using SPSS software version 25. Quantitative variables were summarized as means and standard deviations, and qualitative variables were presented as frequencies and percentages. Chi-square, Fisher-exact tests and T-student were used to univariate analysis. A level of p < 0.05 was considered statistically significant. To adjust on confounding factors, a multivariate binary logistic regression analysis was performed including all variables with p < 0.20 in the univariate analysis. Qualitative data were analyzed manually. The transcripts were read repeatedly to identify the codes and develop an initial codebook. Coding was performed manually. Related codes were grouped into categories that further coalesced into major themes and subthemes. Ethical considerations The study was approved by the Tangier Hospital-University Ethics Committee at Abdelmalek Essaâdi University (approval number: AC85JN/2024, June 27th 2024), and all procedures were conducted in accordance with the ethical principles of the Declaration of Helsinki. Authorization for data collection was also obtained from the Ministry of Health (July 16th, 2024). Informed consent was obtained from all participants after explanation of objectives, voluntariness, and withdrawal rights. Anonymity and confidentiality were strictly maintained. Results Quantitative results Socio-demographic characteristics (n = 300) This study included 300 parents with a mean age of 37.96 ± 8.0 years and a female predominance of 70% (sex ratio F/M = 2.33). The average number of children per parent was 3.02 ± 1.71, ranging from 1 to 10. The mean number of daughters under 15 years of age per parent was 1.45 ± 0.66, with a minimum of 1 and a maximum of 4. Regarding educational level, 24.7% of participants had never attended school, 3.7% had informal education, 35% primary education, 27.3% secondary education, and only 9.3% of respondents reported having higher education. Most of the study population (77.7%) resided in urban areas, with the majority of parents coming from Tangier-Assilah province (78.7%). The distance between participants’ residences and the nearest health center was predominantly 500 m to 1 km (43.3%), while 16% lived more than 5 km away. The majority of participants (84.3%) had health insurance coverage. Household income was low for almost half of the participants (48.3%) and very low for 31.3% of them (Table 1). Table 1Participants’ socio-demographic characteristics and medical historySocio-demographic characteristics% or (mean ± SD, range)Age (n = 300)37.96 ± 8.0 [18–58] yearsSex Female (n = 210)70% Male (n = 90)30%Offspring number (n = 300)3.02 ± 1.71 [1–10]Number of daughters aged under 15 years (n = 300)1.45 ± 0.66 [1–4]Educational level Unschooling (n = 74)24.7% Informal education (n = 11)3.7% Primary education (n = 105)35% Secondary education (n = 82)27.3% University education (n = 28)9.3%Residence area Urban (n = 233)77.7% Rural (n = 67)22.3%Distance between residences and the nearest health center < 500 m (n = 38)12.7% 500 m – 1 km (n = 130)43.3% 1–5 km (n = 84)28% > 5 km (n = 48)16%Health insurance Yes (n = 253)84.3% No (n = 47)15.7%Monthly household income < 2000 MAD (n = 94)31.3% 2000 MAD – 4000 MAD (n = 145)48.3% 4000 MAD – 10 000 MAD (n = 59)19.7% 10 000 MAD – 20 000 MAD (n = 1)0.3% > 20 000 MAD (n = 1)0.3%m meters, km kilometers, MAD Moroccan Dirhams Table 1Participants’ socio-demographic characteristics and medical historySocio-demographic characteristics% or (mean ± SD, range)Age (n = 300)37.96 ± 8.0 [18–58] yearsSex Female (n = 210)70% Male (n = 90)30%Offspring number (n = 300)3.02 ± 1.71 [1–10]Number of daughters aged under 15 years (n = 300)1.45 ± 0.66 [1–4]Educational level Unschooling (n = 74)24.7% Informal education (n = 11)3.7% Primary education (n = 105)35% Secondary education (n = 82)27.3% University education (n = 28)9.3%Residence area Urban (n = 233)77.7% Rural (n = 67)22.3%Distance between residences and the nearest health center < 500 m (n = 38)12.7% 500 m – 1 km (n = 130)43.3% 1–5 km (n = 84)28% > 5 km (n = 48)16%Health insurance Yes (n = 253)84.3% No (n = 47)15.7%Monthly household income < 2000 MAD (n = 94)31.3% 2000 MAD – 4000 MAD (n = 145)48.3% 4000 MAD – 10 000 MAD (n = 59)19.7% 10 000 MAD – 20 000 MAD (n = 1)0.3% > 20 000 MAD (n = 1)0.3%m meters, km kilometers, MAD Moroccan Dirhams Participants’ socio-demographic characteristics and medical history m meters, km kilometers, MAD Moroccan Dirhams Personal and family medical history Among the 300 parents surveyed, 97% (n = 291) reported no personal history of cancer. Among the remaining 3% (n = 9), none had a history of cervical cancer. Regarding family history of any cancer site, 24.3% (n = 73) reported a positive family history, including five participants with a family history of cervical cancer. Knowledge regarding cervical cancer and its association with HPV Among all participants, 69.3% (n = 208) had already heard about cervical cancer (Fig. 1). Awareness was significantly higher among female parents (p < 0.01). Fig. 1Parental knowledge regarding cervical cancer and HPV vaccination Parental knowledge regarding cervical cancer and HPV vaccination Only 10% (n = 30) of participants knew that cervical cancer is caused by a persistent HPV infection, while 90% (n = 270) did not (Fig. 1). There was no statistically significant association between this knowledge and the participant’s sex. The primary source of this knowledge was social media (53.3%), followed by healthcare professionals (23.3%), and other sources such as family or colleagues (23.3%). Parents who had heard of cervical cancer were significantly more likely to be aware of its association with HPV infection (p < 0.001). Regarding knowledge about risk factors, correct answers for each item varied between 14% and 67.9%. The most recognized ones are multiple sexual partners (67.9%), tobacco use (49.8%) and hormonal contraceptive use (47.2%) (Table 2). Table 2Knowledge regarding risk factors of cervical cancerRisk factorsYes %(n)No %(n)Don’t know %(n)Tobacco use49.8% (149) *10.7% (32)39.5% (118)Hormonal contraceptive use47.2% (141) *9.7% (29)43.1% (129)Early age at first pregnancy15.1% (45) *32.1% (96)52.8% (158)Early age of sexual activity22.7% (68) *30.8% (92)46.5% (139)Multiparity14% (42) *45.2% (135)40.8% (122)Multiple sexual partners67.9% (203) *1% (3)31.1% (93)Low socio-economic status22.1% (66) *43.5% (130)34.4% (103)Others16.4% (49) *53.5% (160)30.1% (90)*Correct answers Table 2Knowledge regarding risk factors of cervical cancerRisk factorsYes %(n)No %(n)Don’t know %(n)Tobacco use49.8% (149) *10.7% (32)39.5% (118)Hormonal contraceptive use47.2% (141) *9.7% (29)43.1% (129)Early age at first pregnancy15.1% (45) *32.1% (96)52.8% (158)Early age of sexual activity22.7% (68) *30.8% (92)46.5% (139)Multiparity14% (42) *45.2% (135)40.8% (122)Multiple sexual partners67.9% (203) *1% (3)31.1% (93)Low socio-economic status22.1% (66) *43.5% (130)34.4% (103)Others16.4% (49) *53.5% (160)30.1% (90)*Correct answers Knowledge regarding risk factors of cervical cancer *Correct answers Regarding participants’ knowledge about the severity of cervical cancer, 64.9% recognized mortality, 64.5% recurrence, and 60.5% invasion as potential consequences of the disease. Awareness of the national HPV vaccination program in northern Morocco Only 8.7% (n = 26) of participants in our study were aware of the existence of a national HPV vaccination program (Fig. 1). Among those aware of the program (n = 26), only fifteen of them identified the target age group (girls aged 11–12 years), and only one of them knew that it is intended for girls before their first sexual intercourse. Acceptability of HPV vaccination Among participants, 60% (n = 180) reported being in favor of vaccinating their daughters against HPV. Among those who refused vaccination, the most common reasons were fear of serious adverse effects (65.8%), loss of trust in vaccines following the COVID-19 campaign (52.5%), doubts about the vaccine’s efficacy against cervical cancer (14.2%), and difficulty of talking sexuality with their daughters (3.3%). Other reasons (25.8%) included concerns about limited clinical data, socio-cultural and religious factors such as ensuring daughters abstain from premarital sex, and mistrust of public health programs due to lack of communication from healthcare professionals (Fig. 2). Fig. 2Parental acceptability of HPV vaccination and reasons of hesitancy Parental acceptability of HPV vaccination and reasons of hesitancy Factors associated with acceptability of HPV vaccination Univariate analysis showed that female parents were more likely to accept HPV vaccination for their daughters (p < 0.021). Similarly, participants from rural areas or with no formal education showed significantly better acceptability (p < 0.027 and p < 0.036 respectively). Parents with formal education were predominantly from urban aeras (p < 0.001). No significant associations were found between acceptability and personal or family history of cancer, awareness of cervical cancer and its link to HPV, or awareness of the vaccination program. Increasing age was independently associated with 4.6% higher odds of HPV vaccination hesitancy per one-year increase in age (OR = 1.046; 95% CI: (1.013–1.081; p < 0.006). Similarly, having formal education was associated with 40.4% higher odds of hesitancy compared with no formal education (OR = 2.404; 95% CI: 1.334–4.331; p < 0.004) (Table 3). Table 3Factors associated with HPV vaccination hesitancy among parents of young girlsHPV vaccination hesitancyORa (95% CI)p-valueaORab (95% CI)p-valuebYes %(n) or mean ± SDNo %(n) or mean ± SDAge38.97 ± 7.4637.29 ± 8.291.027 (0.997–1.057)< 0.0741.046 (1.013–1.081) < 0.006 SexFemale35.7% (75)64.3% (135)1 < 0.021 --NSMale50% (45)50% (45)1.800 (1.091–2.969)Residence aeraRural28.4% (19)71.6% (48)1 < 0.027 --NSUrban43.3% (101)56.7% (132)1.933 (1.070–3.491)Formal educationYes43.7% (94)56.3% (121)1.763 (1.033–3.008) < 0.036 2.404 (1.334–4.331) < 0.004 No30.6% (26)69.4% (59)11Personal or family history of cancerYes32.5% (25)67.5% (52)0.655 (0.379–1.130)< 0.127--NSNo42.3% (94)57.7% (128)1Awareness of cervical cancerYes42.8% (89)57.2% (119)1.472 (0.882–2.456)< 0.138--NSNo33.7% (31)66.3% (61)1Knowledge of HPVYes43.3% (13)56.7% (17)1.165 (0.544–2.496)< 0.694----No39.6% (107)60.4% (163)1Awareness of the HPV vaccination programYes38.5% (10)61.5% (16)0.932 (0.408–2.129)< 0.867----No40.1% (110)59.9% (164)195% CI: 95% confidence interval. Values in bold indicate statistical significance (p < 0.05).a = before adjustmentb = after adjustment Table 3Factors associated with HPV vaccination hesitancy among parents of young girlsHPV vaccination hesitancyORa (95% CI)p-valueaORab (95% CI)p-valuebYes %(n) or mean ± SDNo %(n) or mean ± SDAge38.97 ± 7.4637.29 ± 8.291.027 (0.997–1.057)< 0.0741.046 (1.013–1.081) < 0.006 SexFemale35.7% (75)64.3% (135)1 < 0.021 --NSMale50% (45)50% (45)1.800 (1.091–2.969)Residence aeraRural28.4% (19)71.6% (48)1 < 0.027 --NSUrban43.3% (101)56.7% (132)1.933 (1.070–3.491)Formal educationYes43.7% (94)56.3% (121)1.763 (1.033–3.008) < 0.036 2.404 (1.334–4.331) < 0.004 No30.6% (26)69.4% (59)11Personal or family history of cancerYes32.5% (25)67.5% (52)0.655 (0.379–1.130)< 0.127--NSNo42.3% (94)57.7% (128)1Awareness of cervical cancerYes42.8% (89)57.2% (119)1.472 (0.882–2.456)< 0.138--NSNo33.7% (31)66.3% (61)1Knowledge of HPVYes43.3% (13)56.7% (17)1.165 (0.544–2.496)< 0.694----No39.6% (107)60.4% (163)1Awareness of the HPV vaccination programYes38.5% (10)61.5% (16)0.932 (0.408–2.129)< 0.867----No40.1% (110)59.9% (164)195% CI: 95% confidence interval. Values in bold indicate statistical significance (p < 0.05).a = before adjustmentb = after adjustment Factors associated with HPV vaccination hesitancy among parents of young girls 95% CI: 95% confidence interval. Values in bold indicate statistical significance (p < 0.05). a = before adjustment b = after adjustment Qualitative results A focus group discussion was conducted with eight parents of girls under the age of fifteen to explore shared perceptions and social influences regarding HPV vaccination. Transcripts were coded, and themes were identified through an iterative process. Theme 1: awareness and knowledge regarding cervical cancer and HPV Some parents were unaware of cervical cancer: “I had never heard of this disease before”. Others thought they knew it, but they actually confused it with endometrial cancer. They expressed lack of knowledge regarding cervical cancer: “I may have heard of it, but I do not know anything about the disease, its origin, its severity, or its treatment”. Parents were confused about the age of onset, “This cancer can occur after menopause”, and risk factors: “All I know is that the contraceptive pill causes this cancer “. No one knew the link between cervical cancer and HPV. Participants expressed the desire to learn more about cervical cancer and started asking questions about its symptomatology. All participants lacked general knowledge about HPV. It was confused with fungal infections, especially candidiasis: “I know it’s candidiasis...These fungal infections have the potential to evolve and transform into cancer”. They were unaware that HPV is a sexually transmitted infection and believed it could be caught due to poor hygiene. They also thought that leaving fungal infections untreated for a prolonged period could lead to HPV infection. Theme 2: awareness and knowledge regarding HPV vaccination and its national program Most participants had no prior knowledge of the HPV vaccine. They confused it with early childhood vaccines and were unaware that, in Morocco, the program targets 11-year-old girls and consists of two doses administered six months apart. Theme 3: HPV vaccination acceptability After receiving information about HPV vaccination, all the participating parents were excited about the possibility of protecting their daughters from cervical cancer.“…On the contrary, we are happy for our children because they are going to receive this vaccine and therefore will not get this cancer. We wish we could receive the vaccine ourselves as well, so that we would never get this cancer”.“If this vaccine is beneficial for our daughters, then we are obliged to get it done” “…On the contrary, we are happy for our children because they are going to receive this vaccine and therefore will not get this cancer. We wish we could receive the vaccine ourselves as well, so that we would never get this cancer”. “If this vaccine is beneficial for our daughters, then we are obliged to get it done” Theme 4: HPV vaccination hesitancy Initially, the parents did not express any hesitation regarding the HPV vaccination. Therefore, we attempted to explore whether they had issues with vaccines in general. They reported that their only concern was the COVID-19 vaccine, as it was mandatory, and all indicated that they tend to have negative perceptions toward interventions that are imposed. In addition, they highlighted the impact of misinformation spread via social media and their social circles. One parent specifically mentioned a school teacher who discouraged all vaccinations for children, which was particularly concerning for them. Parents explained that they had not vaccinated their daughters because they were unaware of this vaccine. They highlighted a perceived need for information and education among parents, noting that their lack of knowledge was associated with a lack of reliable sources of information.“In my opinion, there is only an issue of awareness; this is what we lack. If the information is clearly and properly explained, we would be convinced, and there would be no reason to refuse”“When we complete our children’s vaccination schedule during early childhood, why are we not informed at that time that we will need to return at around age 11 to vaccinate our daughters against HPV?” “In my opinion, there is only an issue of awareness; this is what we lack. If the information is clearly and properly explained, we would be convinced, and there would be no reason to refuse” “When we complete our children’s vaccination schedule during early childhood, why are we not informed at that time that we will need to return at around age 11 to vaccinate our daughters against HPV?” Theme 5: suggestions to enhance vaccination acceptability Besides their perceived need for information, parents suggested raising awareness among the population through awareness campaigns, social media, and Moroccan news channels. They reported placing great trust in the Moroccan Ministry of Health and consider all news shared on behalf of the Ministry to be credible. Quantitative and qualitative study integration Triangulation of quantitative and qualitative findings revealed both convergence and discrepancies. While 69.3% of participants reported awareness of cervical cancer in the survey, qualitative data suggested that this knowledge was often superficial and frequently confused with other gynecological cancers. Low awareness of both the link between cervical cancer and HPV (10%) and the national HPV vaccination program (8.7%) was similarly observed in the qualitative data. In contrast, HPV vaccination showed 40% hesitancy in the survey and was rated excellent in the qualitative findings. Discussion Our study assessed the acceptability of HPV vaccination among parents of young girls in northern Morocco. The findings reveal critical gaps in awareness and knowledge of both the disease and its vaccine, which may hinder successful vaccination uptake. The quantitative data revealed a female predominance of 70%. This likely reflects the greater tendency for mothers, rather than fathers, to accompany their children to healthcare visits. Only 9.3% of respondents reported higher education, and household income was reported as very low to low for 79.3% of them. This may be explained by the tendency of individuals with higher education and higher income to seek care in the private sector. This mixed-methods study showed that parents lack awareness and knowledge regarding cervical cancer and HPV vaccination. Quantitative data revealed that 69.3% had heard of cervical cancer, and only 10% knew that it is caused by persistent HPV infection. This finding is consistent with other Moroccan studies [15, 16]. Parents were also not aware of the existence of a national HPV vaccination program, knowing that the program was implemented two years ago in the country. Other studies conducted in Morocco also revealed a very low level of awareness of HPV vaccination among parents [17, 18]. This suggests that greater efforts to raise public awareness about the vaccination program are needed. Regarding acceptability of HPV vaccination, 60% of our sample reported being in favor of vaccinating their daughters. A previous study conducted in Morocco in 2011 found a higher acceptability of HPV vaccination, with 76.8% among mothers and 68.9% among fathers [15]. This difference can be explained by general public mistrust in vaccines worldwide following the COVID-19 vaccination campaigns [19]. A systematic review conducted in Morocco showed that the rate of acceptability in parents varied between 35% and 82% [20]. A systematic review conducted in the Arab states of the Middle East and North Africa Region revealed high HPV vaccination acceptability among subpopulations [21]. Among those who refused vaccination, the most common reason were fear of serious adverse effects, as documented in other studies [15, 18, 22, 23]. This finding highlights a clear need to inform the population about the safety and effectiveness of the HPV vaccine and to directly address prevailing doubts and concerns [24]. A very small proportion of parents refused vaccination, believing that their daughters would never contract HPV because they were expected to abstain from premarital sexual activity. Notably, this theme did not emerge in our qualitative findings, even when they were explicitly informed that the vaccine protects against a sexually transmitted infection (STI), which is encouraging. Another study conducted in Morocco reported similar findings [15]. In contrast, several other studies have reported that religious and moral convictions regarding abstinence until marriage negatively influenced vaccination acceptability [25, 26]. Our analysis showed no significant association between awareness of cervical cancer, its link to HPV and vaccination program awareness, on one hand, and vaccination acceptability on the other hand. This may be due to the fact that acceptability was assessed after participants had been provided with brief information on the preventive role of HPV vaccination in cervical cancer, as baseline awareness of both the disease and its vaccination was very low. As a result, the influence of prior knowledge could not be captured. Notably, even after receiving information, 40% of participants remained hesitant, indicating that factors beyond knowledge play a role in vaccination acceptability. Older age and formal education were independently linked to higher HPV vaccination hesitancy, a finding that has also been reported in a previous research [14]. This suggests that awareness and communication strategies should be shaped according to the socio-demographic characteristics of the target population. Furthermore, access to many sources of information may paradoxically increase exposure to misleading content as highlighted in the qualitative findings. This may partly explain the greater hesitancy observed among educated parents. Findings from the qualitative component revealed a very high level of acceptability, suggesting that low vaccination uptake is primarily driven by limited awareness rather than true hesitancy. Another study supports the same finding [21]. The qualitative findings revealed a perceived need for reliable sources of information. Therefore, efforts should be made to arise public campaigning and enhance recommendations from healthcare providers. Strengths and limitations This is the first study exploring parental acceptability of HPV vaccination in Morocco after the implementation of the national HPV vaccination program in 2022. We used a mixed-methods approach, combining quantitative data survey and qualitative insights from a focus group. This design allows to quantify parental acceptability while also exploring perceptions and motivations in depth, strengthening the validity of the findings. The study targeted a relevant population, and face-to-face data collection facilitated participation and accurate responses compared with auto-administered surveys. However, the study has some limitations. The cross-sectional design does not allow for causal inferences between factors and acceptability. Additionally, the study was conducted in a single center, which may limit generalizability to all the northern region. However, Mohammed VI University Hospital of Tangier is the only university hospital in this region and serves as a major referral center for patients from several provinces in northern Morocco. Conclusion Despite challenges facing the HPV vaccination program in Morocco, our study indicates that parents of young girls are generally receptive to vaccination. Nevertheless, limited awareness remains a major concern, highlighting the need to strengthen public education on cervical cancer, its asymptomatic nature, and the importance of both primary and secondary prevention. Barriers to HPV vaccination should be further explored through implementation research to inform effective strategies. Supplementary Information Supplementary Material 1. Supplementary Material 1.